Venn Life Sciences Holdings PLC EUR1.4m contract win with US firm (6509W)

TIDMVENN

RNS Number : 6509W

Venn Life Sciences Holdings PLC

11 November 2014

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Group")

EUR1.4million contract with US firm for European Trial

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the signing of an agreement worth over EUR1.4 million to conduct a European wide Phase II study for a US based company.

The deal comes on the back of multiple significant contract signings for Venn this year and sees the Company expanding its US customer base. Including this contract, Venn has announced new business wins totaling EUR8m in the past six months. This volume of business represents a major step change for Venn and justifies the significant investment in personnel and infrastructure in the past 18 months.

Speaking about the agreement, Venn CEO, Tony Richardson stated: "The recent project wins demonstrate that our strategy of expanding our core services, our locations and our teams is coming to fruition for us as a company, and for our shareholders and our stakeholders. We now have a solid book of profitable contracts and a healthy pipeline of opportunities, which gives us confidence that we will deliver further growth in 2015."

Enquiries:

 
Venn Life Sciences Holdings Plc                                  www.vennlifesciences.com 
Tony Richardson, Chief Executive Officer                             Tel: +353 154 99 341 
Orla Mc Guinness, Marketing Manager                                   Tel: +594 694410116 
Zeus Capital (Nominated Adviser and 
 Broker) 
Ross Andrews/Andrew Jones (Corporate                             Tel: +44 (0)161 831 1512 
 Finance) 
Dominic Wilson (Institutional Sales)                             Tel: +44 (0)20 7533 7721 
 
Walbrook PR Ltd                           Tel: +44 (0)20 7933 8780 or venn@walbrookpr.com 
Paul McManus                                                     Mob: +44 (0)7980 541 893 
Lianne Cawthorne                                                 Mob: +44 (0)7584 391 303

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCURUBRSSAAAAA

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024